2015 annual financial data

CytomX Therapeutics 2015 Financial results

Direct answer

Revenue was 7,712,000 USD.

Operating income was -33,203,000 USD and net income was -35,374,000 USD.
Operating cash flow was -27,415,000 USD.

Get free CytomX Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,712,000 USD
Operating income
-33,203,000 USD
Net income
-35,374,000 USD
Operating cash flow
-27,415,000 USD